Press Room

JDRF in the Globe and Mail, November 12, 2013: Beyond searching for cure, JDRF aims to improve the lives of people with T1D.

JDRF showcases the Outreach Program including tools and resources available; highlights Eli Lilly’s exciting new program; and discusses how to get involved through November and beyond.


Canadians Living With Type 1 Diabetes for 50 Years Can Have a Significant Impact in Discovering Factors for Success in T1D Research

JDRF is excited to support a nationwide research study exploring longevity in type 1 diabetes (T1D). Toronto-based researchers at Mount Sinai Hospital are creating a national registry of Canadians who have been living with T1D for 50 years or more, and invite them to participate in a mail-based national ...


JDRF in the Globe and Mail, November 7, 2013: Advances in type 1 diabetes (T1D) treatments making difference for family facing a double challenge.

JDRF profiles a family living with T1D; discusses diabetes in Canada; and how JDRF-funded research is making a difference.


JDRF Launches Diabetes by Numbers Social Media Campaign for Diabetes Awareness Month

Show us your finger and share your support! With an aim to raise money for diabetes research, JDRF has launched its "Diabetes by Numbers" social media campaign on Facebook and Twitter to encourage Canadians to share a photo with a blue circle on their index finger ...


JDRF as the Charity of Choice for Barrie Member of Parliament at the 2013 NYC Marathon

TORONTO, ON (October 31, 2013) - Patrick Brown, Member of Parliament for Barrie, Ontario and Chair of the All-Party Juvenile Diabetes Caucus on Parliament Hill, will be participating in the New York City Marathon to create awareness for type 1 diabetes and raise vital funds that will help support world ...


JDRF Commits $5M to a Novel Venture-Creating Entity Called T1D Innovations

Under PureTech’s direction, in collaboration with leading T1D-focused organizations, T1D Innovations will create and fund companies to translate key medical discoveries into novel type 1 diabetes products


Sansum Diabetes Research Institute, University of California, Santa Barbara Conduct Innovative Artificial Pancreas – Ultra-Rapid-Acting Inhaled Insulin Trial Funded by JDRF

JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin. 


JDRF Honors Researchers Whose Insights on Early Type 1 Diabetes Development Have Set the Stage for Disease Prevention in Children

The three winners of JDRF’s 2013  Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award have provided critical insights into the type 1 diabetes disease process in young children, laying the groundwork for targeted disease prevention strategies


JDRF Applauds Launch of New Low Glucose Suspend Technology

 JDRF, the leading global organization funding type 1 diabetes (T1D) research, today applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels ...


JDRF Canada Opens the Market

On Friday, September 20, Dave Prowten, President & CEO, JDRF Canada, and Charlotte Romain, Youth Ambassador, JDRF Canada joined Eleanor Fritz, Director, Compliance & Disclosure, Toronto Stock Exchange to open the market and raise awareness of the 25th annual ...


Lets turn type one into type none